相关实验视频
Updated: May 5, 2026

06:47
A Murine Model of Vertical Sleeve Gastrectomy
Published on: December 18, 2017
11.1K
与普通人群相比,腹部外科手术显著降低了从糖尿病前期到糖尿病的进展:15年单一机构数据:
Luis Pina1, Joseph Nguyen-Lee1, G Craig Wood1
1Division of Bariatric and Foregut Surgery, The Obesity Institute, Geisinger Health System, Danville, Pennsylvania.
概括
腹部外科手术大大减少了从糖尿病前期到II型糖尿病的进展. 对于糖尿病预防,Roux-en-Y胃绕道显示出比袖子胃切除更大的保护效果.
科学领域:
- 代谢手术 代谢手术
- 内分泌学 在内分泌学.
- 肥胖医学 肥胖医学
背景情况:
- 有限的研究存在于减肥手术对糖尿病前期 (PDM) 到II型糖尿病 (T2DM) 进展的影响.
- 了解这种影响对于管理肥胖个体的代谢健康至关重要.
研究的目的:
- 为了比较PDM患者的T2DM进展率,这些患者接受了减肥手术,与匹配的非手术队列相比.
- 为了评估Roux-en-Y胃绕道 (RYGB) 和袖子胃切除术 (SG) 之间的T2DM进展的差异.
主要方法:
- 对1326名患有PDM的致病性肥胖患者进行RYGB或SG (2001-2022) 的回顾性分析.
- 根据HbA1c,年龄,性别和BMI选择了匹配的非手术对照.
- 使用Kaplan-Meier和Cox回归分析来评估T2DM诊断的时间.
主要成果:
- 腹部外科手术患者的PDM到T2DM进展显著降低:在15年后为6.7%,而对照组为68.7% (HR 19.8,P < .0001).
- 袖子胃切除术患者的T2DM进展率比RYGB患者高4倍 (HR4.01,P = .0014).
结论:
- 腹腔外科手术在防止T2DM从PDM转化方面非常有效.
- 在缓解T2DM进展方面,RYGB显示出比SG更大的优势.
相关概念视频
Carbohydrate Metabolism
10.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.4K
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28

